Oct 15, 2021 | 2021, Events, Scientific
Stifel Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri through a series of one-on-one meetings. Co-founder, CEO and CSO, Prof. Dario Neri is giving a presentation on November 16,...Oct 5, 2021 | 2021, Events, Scientific
Dario Neri, co-founder, CEO and CSO, is giving a presentation focused on Tripokin, a novel fusion protein capable of an exceptionally selective uptake at the tumor site. The product contains two highly synergistic cytokine moieties (interleukin-2 and tumor necrosis...Oct 5, 2021 | 2021, Events, Scientific
Dario Neri, co-founder, CEO and CSO, is giving a presentation to address the question on how to achieve the therapeutic dose at the tumor site with cytokine-based targeted products. Roberto De Luca, Head of Antibody Therapeutics at Philogen, is also giving a...Oct 5, 2021 | 2021, Events, Scientific
Philogen is presenting a ePoster on the results of the run-in part of the Phase II study with Fibromun plus Dacarbazine for patients with in third or later line advanced/metastatic soft tissue sarcoma. See here for more details.Oct 5, 2021 | 2021, Events, Scientific
Philogen participates at the BIO-Europe Digital 2021 BIO-Europe (informaconnect.com) – 2021, the international partnering event in the life science and pharma industry, on October 25-28, 2021 Please meet with us in case you are interested in a collaboration or...
Recent Comments